Abstract
Mucilages, and in particular plant mucilages, have gained more attention over the last few decades due to their reputable medicinal properties. Some publications have appeared in reputable Scientific Journals that have made appreciable contributions to the discovery of the functions and utilizations of such naturally occurring products. Therapeutic value of mucilages has been extended to wound healing, diabetes, immunostimulation, cancer, angiotensin converting enzyme inhibition, stomachic, and antioxidant properties. Based on their sustaining capacities as well as binding and gelling properties, mucilages have been proposed to be one of the most useful materials to modulate drug delivery. Chemical analysis reveals that generally these contain monosachrides along with a range of other organic and inorganic components. Although physiological properties of various plant mucialges have been described, it still remains uncertain as to which of the component(s) is responsible for these physiological properties. Further research needs to be done to unravel the myth surrounding the biological activities and the functional properties of them. This review presents an overview of the current status and knowledge on the applications of plant mucilages as therapeutic agent and pharmaceutical additives.
Keywords: Drug delivery, Mucilages, Pharmaceutical Additive
Current Drug Delivery
Title:Potential of Plant Mucilages in Pharmaceuticals and Therapy
Volume: 10 Issue: 2
Author(s): Jyoti Wadhwa, Anroop Nair and Rachna Kumria
Affiliation:
Keywords: Drug delivery, Mucilages, Pharmaceutical Additive
Abstract: Mucilages, and in particular plant mucilages, have gained more attention over the last few decades due to their reputable medicinal properties. Some publications have appeared in reputable Scientific Journals that have made appreciable contributions to the discovery of the functions and utilizations of such naturally occurring products. Therapeutic value of mucilages has been extended to wound healing, diabetes, immunostimulation, cancer, angiotensin converting enzyme inhibition, stomachic, and antioxidant properties. Based on their sustaining capacities as well as binding and gelling properties, mucilages have been proposed to be one of the most useful materials to modulate drug delivery. Chemical analysis reveals that generally these contain monosachrides along with a range of other organic and inorganic components. Although physiological properties of various plant mucialges have been described, it still remains uncertain as to which of the component(s) is responsible for these physiological properties. Further research needs to be done to unravel the myth surrounding the biological activities and the functional properties of them. This review presents an overview of the current status and knowledge on the applications of plant mucilages as therapeutic agent and pharmaceutical additives.
Export Options
About this article
Cite this article as:
Wadhwa Jyoti, Nair Anroop and Kumria Rachna, Potential of Plant Mucilages in Pharmaceuticals and Therapy, Current Drug Delivery 2013; 10 (2) . https://dx.doi.org/10.2174/1567201811310020006
DOI https://dx.doi.org/10.2174/1567201811310020006 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting of Low-Molecular Weight Drugs to Mammalian Mitochondria
Drug Design Reviews - Online (Discontinued) Neutrophil Cell Count is Related to Hypertension in Workers: A Cross- Sectional Study
Vascular Disease Prevention (Discontinued) Modelling Human Disease with Pluripotent Stem Cells
Current Gene Therapy Treatment Considerations of Clinical Physician on Hypertension Management in Asia
Current Hypertension Reviews A Timely Review of State-of-the-Art Chronopharmaceuticals Synchronized with Biological Rhythms
Current Drug Delivery Flavonoid Enriched Fraction of Campylandra aurantiaca Attenuates Carbon Tetrachloride Induced Oxidative DNA Damage in Mouse Peritoneal Macrophages in Animal Model
Current Drug Discovery Technologies Role of Vitamin D in Vascular Complications and Vascular Access Outcome in Patients with Chronic Kidney Disease
Current Medicinal Chemistry Targeting the Multifaceted HuR Protein, Benefits and Caveats
Current Drug Targets Developmental Changes in the Roles of Patients and Families in Type 1 Diabetes Management
Current Diabetes Reviews Cardiovascular Disease among Patients with Diabetes: The Current Scenario in Saudi Arabia
Current Diabetes Reviews Lack of Association between Genetic Polymorphism of Circadian Genes (PER2, PER3, CLOCK and OX2R) with Late Onset Depression and Alzheimer's Disease in a Sample of a Brazilian Population (Circadian Genes, Late-Onset Depression and Alzheimer's Disease)
Current Alzheimer Research Aldose Reductase Inhibition: Emerging Drug Target for the Treatment of Cardiovascular Complications
Recent Patents on Cardiovascular Drug Discovery Conventional and Non-Conventional Targets of Natural Products in the Management of Diabetes Mellitus and Associated Complications
Current Medicinal Chemistry Ribosome Inactivating Proteins (RIPs) from Momordica charantia for Anti Viral Therapy
Current Molecular Medicine Computational and Experimental Approaches to Design Inhibitors of Amylin Aggregation
Current Drug Targets Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Cholesterol, Lipids, Amyloid Beta, and Alzheimers
Current Alzheimer Research Coronavirus-related Disease Pandemic: A Review on Machine Learning Approaches and Treatment Trials on Diagnosed Population for Future Clinical Decision Support
Current Medical Imaging Genetic Lipodystrophies: Models for Insulin Resistance
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Mitochondrial Dysfunction and Targeted Drugs: A Focus on Diabetes
Current Pharmaceutical Design